Regenerating the Injured Spinal Cord at the Chronic Phase by Engineered iPSCs-Derived 3D Neuronal Networks.

3D neuronal network chronic phase injury differentiation induced pluripotent stem cells spinal cord injury tissue engineering tissue implants

Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
04 2022
Historique:
received: 15 12 2021
pubmed: 8 2 2022
medline: 16 4 2022
entrez: 7 2 2022
Statut: ppublish

Résumé

Cell therapy using induced pluripotent stem cell-derived neurons is considered a promising approach to regenerate the injured spinal cord (SC). However, the scar formed at the chronic phase is not a permissive microenvironment for cell or biomaterial engraftment or for tissue assembly. Engineering of a functional human neuronal network is now reported by mimicking the embryonic development of the SC in a 3D dynamic biomaterial-based microenvironment. Throughout the in vitro cultivation stage, the system's components have a synergistic effect, providing appropriate cues for SC neurogenesis. While the initial biomaterial supported efficient cell differentiation in 3D, the cells remodeled it to provide an inductive microenvironment for the assembly of functional SC implants. The engineered tissues are characterized for morphology and function, and their therapeutic potential is investigated, revealing improved structural and functional outcomes after acute and chronic SC injuries. Such technology is envisioned to be translated to the clinic to rewire human injured SC.

Identifiants

pubmed: 35128819
doi: 10.1002/advs.202105694
pmc: PMC9008789
doi:

Substances chimiques

Biocompatible Materials 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2105694

Informations de copyright

© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

J Vis Exp. 2015 Apr 07;(98):
pubmed: 25938297
Annu Rev Neurosci. 2001;24:87-105
pubmed: 11283306
Brain Res Dev Brain Res. 2002 Mar 31;134(1-2):87-92
pubmed: 11947939
AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1587-94
pubmed: 15956535
Nat Med. 2004 Jun;10(6):610-6
pubmed: 15156204
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12704-9
pubmed: 20615974
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E820-E829
pubmed: 28096400
Neuron. 2016 May 4;90(3):437-51
pubmed: 27151637
Development. 2019 Nov 25;146(22):
pubmed: 31767567
Exp Neurol. 2015 Dec;274(Pt B):90-9
pubmed: 26028310
ACS Nano. 2011 Jan 25;5(1):227-36
pubmed: 21189038
Science. 2021 Nov 12;374(6569):848-856
pubmed: 34762454
Stem Cells. 2020 Jan;38(1):22-33
pubmed: 31408238
Brain Res Brain Res Rev. 2005 Jul;49(1):48-64
pubmed: 15960986
Adv Mater. 2019 Jan;31(1):e1803895
pubmed: 30406960
Neuroimage. 2011 Apr 1;55(3):1024-33
pubmed: 21232610
Front Bioeng Biotechnol. 2021 Mar 18;9:639765
pubmed: 33816451
Biomed Mater. 2015 May 13;10(3):034106
pubmed: 25970726
Front Integr Neurosci. 2013 Feb 01;7:3
pubmed: 23378830
Regen Ther. 2019 Aug 08;11:182-191
pubmed: 31453273
J Neurotrauma. 2015 Mar 15;32(6):397-402
pubmed: 25111333
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25212-25218
pubmed: 32999065
Neural Regen Res. 2015 Apr;10(4):509-13
pubmed: 26170799
J Neurotrauma. 2010 Mar;27(3):587-98
pubmed: 20001686
Expert Rev Mol Med. 2009 Dec 08;11:e37
pubmed: 19968910
Front Cell Neurosci. 2020 Apr 03;14:78
pubmed: 32317938
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7483-7492
pubmed: 30923117
Phys Ther. 2000 Jul;80(7):673-87
pubmed: 10869130
Neural Regen Res. 2018 Mar;13(3):502-509
pubmed: 29623937
Semin Cell Dev Biol. 2019 Jan;85:78-83
pubmed: 29141180
Adv Healthc Mater. 2018 Jan;7(1):
pubmed: 28845922
Development. 2020 May 28;147(10):
pubmed: 32467294
Adv Sci (Weinh). 2022 Apr;9(11):e2105694
pubmed: 35128819
Nat Med. 2018 May;24(4):484-490
pubmed: 29480894
Curr Top Dev Biol. 2018;130:245-274
pubmed: 29853179
Brain. 2011 Aug;134(Pt 8):2248-60
pubmed: 21764818
Neuron. 2014 Aug 20;83(4):789-96
pubmed: 25123310
Biofabrication. 2014 Sep;6(3):035023
pubmed: 25162210
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Stem Cell Reports. 2016 Jan 12;6(1):1-8
pubmed: 26724902
Nat Rev Cancer. 2011 Mar;11(3):188-97
pubmed: 21326323

Auteurs

Lior Wertheim (L)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
The Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 6997801, Israel.
The Department of Materials Science and Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, 6997801, Israel.

Reuven Edri (R)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.

Yona Goldshmit (Y)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
Steyer School of Health Professions, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, 6997801, Israel.

Tomer Kagan (T)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.

Nadav Noor (N)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.

Angela Ruban (A)

Steyer School of Health Professions, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, 6997801, Israel.

Assaf Shapira (A)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.

Irit Gat-Viks (I)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.

Yaniv Assaf (Y)

School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 6997801, Israel.

Tal Dvir (T)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
The Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 6997801, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 6997801, Israel.
The Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, 6997801, Israel.
Sagol Center for Regenerative Biotechnology, Tel Aviv University, Tel Aviv, 6997801, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH